Find a Lawyer
Book an appointment with us, or search the directory to find the right lawyer for you directly through the app.
Find out more
English Law: Keep calm and mind the precedent
In May Law Update’s edition, we examined the continued relevance of English law across MENA jurisdictions and why it remains a cornerstone of commercial transactions, dispute resolution, and cross-border deal structuring.
From the Dubai Court’s recognition of Without Prejudice communications to anti-sandbagging clauses, ESG, joint ventures, and the classification of warranties, our contributors explore how English legal concepts are being applied, interpreted, and adapted in a regional context.
With expert insight across sectors, including capital markets, corporate acquisitions, and estate planning, this issue underscores that familiarity with English law is no longer optional for businesses in MENA. It is essential.
2025 is set to be a game-changer for the MENA region, with legal and regulatory shifts from 2024 continuing to reshape its economic landscape. Saudi Arabia, the UAE, Egypt, Iraq, Qatar, and Bahrain are all implementing groundbreaking reforms in sustainable financing, investment laws, labor regulations, and dispute resolution. As the region positions itself for deeper global integration, businesses must adapt to a rapidly evolving legal environment.
Our Eyes on 2025 publication provides essential insights and practical guidance on the key legal updates shaping the year ahead—equipping you with the knowledge to stay ahead in this dynamic market.
A complete spectrum of legal services across jurisdictions in the Middle East & North Africa.
Kuwait: Ministry of Health Restrictions on the Supply of Non-registered Medical Products
Kuwait’s Ministry of Health (“MOH”) issued Resolution No. 100 of 2023 in April 2023 (“Resolution 100/2023”). Resolution 100/2023 repeals a previous MOH resolution from 2022, which regulated the mechanism for importing non-registered medicines and pharmaceutical products. Further, it adds a new article to Resolution No. 361 of 2019. The new article allows for medicines used in the diagnosis, treatment, or prevention of diseases and registered with international supervisory authorities without any alternative replacements available, to be registered at the request of authorities at the Ministry of Health. This will be done in accordance with the requirements set out by the Department for the Registration and Control of Medical and Plant Based Medicines at the Ministry of Health.
How can we help?
Al Tamimi & Company are able assist in ensuring compliance with the evolving Ministry of Health Resolutions in Kuwait.
Key Contacts
l.alhammad@tamimi.comSpread the news
Stay updated
To learn more about our services and get the latest legal insights from across the Middle East and North Africa region, click on the link below.
